BridgeBio Pharma, Inc. reports

Company location: Palo Alto, CA
Fiscal year end: 31 December

BridgeBio Pharma, Inc. has filed 812 SEC EDGAR filings since 19 Jun 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 626-650 of 812 matching filings.

Per page

25

Current page

26

S-8 File 333-239718

FORM S-8

Filing date: 07 Jul 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jul 2020
Reporting date: 01 Jul 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jul 2020
Reporting date: 01 Jul 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jul 2020
Reporting date: 01 Jul 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Jul 2020
Reporting date: 30 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jun 2020
Reporting date: 23 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jun 2020
Reporting date: 23 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jun 2020
Reporting date: 23 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 25 Jun 2020
Reporting date: 23 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 25 Jun 2020
Reporting date: 23 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 25 Jun 2020
Reporting date: 23 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38959

8-K

Filing date: 24 Jun 2020
Reporting date: 23 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Jun 2020
Reporting date: 08 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Jun 2020
Reporting date: 08 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Jun 2020
Reporting date: 08 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38959

8-K

Filing date: 08 Jun 2020
Reporting date: 02 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jun 2020
Reporting date: 03 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jun 2020
Reporting date: 03 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jun 2020
Reporting date: 03 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jun 2020
Reporting date: 03 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jun 2020
Reporting date: 02 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jun 2020
Reporting date: 02 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jun 2020
Reporting date: 02 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jun 2020
Reporting date: 02 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jun 2020
Reporting date: 02 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .